The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Htr2a gene and 5-HT2A receptor expression in the cerebral cortex studied using genetically modified mice
Open accessAbstract
Serotonin receptors of the 5-HT(2A) subtype are robustly expressed in the cerebral cortex where they have been implicated in the pathophysiology and therapeutics of mental disorders and the actions of hallucinogens. Much less is known, however, about the specific cell types expressing 5-HT(2A) receptors in cortex. In the current study we use immunohistochemical and electrophysiological approaches in genetically modified mice to address the expression of the Htr2a gene and 5-HT(2A) receptors in cortex. We first use an EGFP-expressing BAC transgenic mice and identify three main Htr2A gene expressing neuronal populations in cortex. The largest of these cell populations corresponds to layer V pyramidal cells of the anterior cortex, followed by GABAergic interneurons of the middle layers, and non-pyramidal cells of the subplate/Layer VIb. We then use 5-HT(2A) receptor knockout mice to identify an antibody capable of localizing 5-HT(2A) receptors in brain and use it to map these receptors. We find strong laminar expression of 5-HT(2A) receptors in cortex, especially along a diffuse band overlaying layer Va. This band exhibits a strong anteroposterior gradient that closely matches the localization of Htr2A expressing pyramidal cells of layer V. Finally we use electrophysiological and immunohistochemical approaches to show that most, but not all, GABAergic interneurons of the middle layers are parvalbumin expressing Fast-spiking interneurons and that these cells are depolarized and excited by serotonin, most likely through the activation of 5-HT(2A) receptors. These results clarify and extend our understanding of the cellular distribution of 5-HT(2A) receptors in the cerebral cortex.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In rodents, this expression pattern has been confirmed using immunohistochemistry (203–206), light and electron microscope immunocytochemistry (203), in situ hybridization (207, 208), receptor autoradiography (209), and transgenic mice expressing EGFP under control of the 5-HT2A receptor promoter (210).”
From Psychedelics and Other Psychoplastogens for Treating Mental Illness. (2021) · cites this paper as [210]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,211
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
Gong, S., Zheng, C., Doughty, M. L., Losos, K., Didkovsky, N., Schambra, U. B., Nowak, N. J., Joyner, A., Leblanc, G., Hatten, M. E., et al. (2003) · Nature · doi:10.1038/nature02033 · Cited by 2,108
Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks
Bartos, M., Vida, I., & Jonas, P. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2044 · Cited by 2,070
Pazos, Á., & Palacios, J. M. (1985) · Brain Research · doi:10.1016/0006-8993(85)90856-x · Cited by 1,855
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex
The Petilla Interneuron Nomenclature Group (PING) (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2402 · Cited by 1,491
GABAergic cell subtypes and their synaptic connections in rat frontal cortex
Kawaguchi, Y. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.6.476 · Cited by 1,416
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Cited by
Sorted by citations
Items 101–200 of 206
Wright, A., Zapata, A. G., Hoffman, A. F., Necarsulmer, J., Coke, L. M., Svarcbahs, R., Richie, C. T., Pickel, J. M., Hope, B. T., Harvey, B. K., et al. (2021) · eNeuro · doi:10.1523/eneuro.0017-21.2021 · Cited by 18
A suite of engineered mice for interrogating psychedelic drug actions
Chiu, Y.-T., Deutch, A. Y., Wang, W., Schmitz, G. P., Huang, K. L., Koçak, D. D., Llorach, P., Bowyer, K., Liu, B., Sciaky, N., et al. (2026) · Nature Neuroscience · doi:10.1038/s41593-026-02375-0 · Cited by 20
Spindle, M. S., & Thomas, M. P. (2014) · Physiological Reports · doi:10.14814/phy2.12003 · Cited by 15
5-HT2A Receptors and BDNF Regulation: Implications for Psychopathology
Jaggar, M., & Vaidya, V. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_17 · Cited by 15
Neurotoxicological profile of the hallucinogenic compound 25I-NBOMe
Herian, M., Wojtas, A., Maćkowiak, M., Wawrzczak‐Bargieła, A., Solarz, A., Bysiek, A., Madej, K., & Gołembiowska, K. (2022) · Scientific Reports · doi:10.1038/s41598-022-07069-8 · Cited by 15
Shiraki, A., Saito, F., Akane, H., Akahori, Y., Imatanaka, N., Itahashi, M., Yoshida, T., & Shibutani, M. (2015) · Journal of Applied Toxicology · doi:10.1002/jat.3140 · Cited by 15
Psychiatric Disorders - Worldwide Advances
Uehara, T. (2011) · InTech eBooks · doi:10.5772/1289 · Cited by 16
Fuchs, C., Gennaccaro, L., Ren, E., Galvani, G., Trazzi, S., Medici, G., Loi, M., Conway, E., Devinsky, O., Rimondini, R., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107746 · Cited by 17
Arias, H. R., Rudin, D., Hines, D. J., Contreras, A., Gulsevin, A., Manetti, D., Anouar, Y., Deurwaerdère, P. D., Meiler, J., Romanelli, M. N., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176329 · Cited by 16
Meccia, J., Lopez, J., & Bagot, R. C. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06297-0 · Cited by 13
Leptourgos, P., Bouttier, V., Denève, S., & Jardri, R. (2021) · PsyArXiv (OSF Preprints) · doi:10.1016/j.neubiorev.2022.104593 · Cited by 16
Pehek, E. A., & Hernan, A. E. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.01.029 · Cited by 12
Neuromodulation of Hippocampal Cells and Circuits
Cobb, S., & Lawrence, J. J. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0996-1_7 · Cited by 13
Kojic, M., Saelens, J., Kadriu, B., Zarate, C. A., & Kraus, C. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_313 · Cited by 12
Cellular Effects of Serotonin in the CNS
Andrade, R., & Beck, S. G. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70080-1 · Cited by 12
Barzan, R., Bozkurt, B., Nejad, M. M., Süß, S. T., Surdin, T., Böke, H., Spoida, K., Azimi, Z., Grömmke, M., Eickelbeck, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51861-1 · Cited by 12
Buchborn, T., Lyons, T., Song, C., Feilding, A., & Knöpfel, T. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120903465 · Cited by 13
Rangel‐Barajas, C., Estrada‐Sánchez, A. M., Barton, S. J., Luedtke, R. R., & Rebec, G. V. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.11.001 · Cited by 10
Serotonin 2A receptors and cannabinoids
Ibarra‐Lecue, I., Dı́ez-Alarcia, R., & Urigüen, L. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.004 · Cited by 11
Villalba, S., González, B., Junge, S., Bernardi, A., González, J., Fagúndez, C., Torterolo, P., Carrera, I., Urbano, F. J., & Bisagno, V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020687 · Cited by 10
PACAP–PAC1 Signaling Regulates Serotonin 2A Receptor Internalization
Hayata‐Takano, A., Shintani, Y., Moriguchi, K., Encho, N., Kitagawa, K., Nakazawa, T., & Hashimoto, H. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.732456 · Cited by 10
Vesicular Glutamate Release from Feeder-FreehiPSC-Derived Neurons
Baldassari, S., Cervetto, C., Amato, S., Fruscione, F., Balagura, G., Pelassa, S., Musante, I., Iacomino, M., Traverso, M., Corradi, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810545 · Cited by 10
Butler, M., Bird, C., Maggio, C., Durden, A., Modlin, N. L., Campbell‐Coker, K., Edwards, M. J., Pick, S., Millman, L. S. M., Lowery, E., et al. (2024) · Wellcome Open Research · doi:10.12688/wellcomeopenres.22543.1 · Cited by 9
Madden, M. B., Schaefgen, C., Vedak, B., Kwon, J., Pedra, K. S. D., Sheats, S. H., Puché, A. C., Wolff, S. B. E., & Mathur, B. N. (2025) · Nature Communications · doi:10.1038/s41467-025-62980-8 · Cited by 14
Rovira, V., & Geijo‐Barrientos, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150092 · Cited by 9
Tang, Z.-H., Yu, Z., Li, Q., Zhang, X., Muhetaer, K., Wang, Z., Xu, P., & Shen, H. (2023) · Psychopharmacology · doi:10.1007/s00213-023-06366-y · Cited by 9
Gasperi, R. D., Garcia, G. S. P., Sosa, M. A. G., Perez, G. M., Abutarboush, R., Kawoos, U., Hof, P. R., Zhu, C. W., Ahlers, S. T., & Elder, G. A. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1594335 · Cited by 7
Yuan, S., Wang, N., Yao, Y., Liu, J., Gao, M., Mo, H., Zhang, S., & Su, R. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.08.018 · Cited by 7
Neurotransmitters and Intermittent Explosive Disorder
Lee, R., & Coccaro, E. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813858-8.00005-x · Cited by 8
Sun, Y., Chebolu, S., Henry, D., Lankireddy, S., & Darmani, N. A. (2022) · BMC Neuroscience · doi:10.1186/s12868-021-00686-5 · Cited by 7
Dearnley, B., Dervinis, M., Shaw, M., & Okun, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.08.22.457198 · Cited by 8
Cortical Correlates of Psychedelic-Induced Shaking Behavior Revealed by Voltage Imaging
Buchborn, T., Lyons, T., Song, C., Feilding, A., & Knöpfel, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119463 · Cited by 7
The Key Role of Intracellular 5-HT2A Receptors: A Turning Point in Psychedelic Research?
Sapienza, J. (2023) · Psychoactives · doi:10.3390/psychoactives2040018 · Cited by 6
Serotonergic Modulation of the Prefrontal Cortex: From Neurons to Brain Waves
Victoria, M. (2011) · InTech eBooks · doi:10.5772/25572 · Cited by 6
Wojtas, A., Herian, M., Maćkowiak, M., Solarz, A., Wawrzczak‐Bargieła, A., Bysiek, A., Noworyta, K., & Gołembiowska, K. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109713 · Cited by 6
Similar serotonin-2A receptor binding in rats with different coping styles or levels of aggression
Visser, A. K. D., Ettrup, A., Klein, A. B., van Waarde, A., Bosker, F. J., Meerlo, P., Knudsen, G. M., & de Boer, S. F. (2015) · Synapse · doi:10.1002/syn.21810 · Cited by 6
Willmann, M., Hegger, J., Neumaier, B., & Ermert, J. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00658 · Cited by 6
Dumas, N., Sallanon, M. M., Fender, P., Tournier, B. B., Ginovart, N., Charnay, Y., & Millet, P. (2015) · Molecular Imaging · doi:10.2310/7290.2015.00006 · Cited by 6
Electrophysiological mechanisms of psychedelic drugs: A systematic review
Jiménez, J. H., Kaup, K., & Aru, J. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106649 · Cited by 7
Sun, Y., Chebolu, S., Skegrud, S., Kamali, S., & Darmani, N. A. (2023) · BMC Neuroscience · doi:10.1186/s12868-022-00766-0 · Cited by 5
Gonzalez‐Rothi, E. J., Allen, L. L., Seven, Y. B., Ciesla, M. C., Holland, A., Santiago, J. V., & Mitchell, G. S. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114808 · Cited by 5
Pasculli, G., Busan, P., Jackson, E. S., Alm, P. A., Gregorio, D. D., Maguire, G. A., Goodwin, G. M., Gobbi, G., Erritzøe, D., & Carhart-Harris, R. L. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1402549 · Cited by 6
Puzerey, P. A., Kodama, N. X., & Galán, R. F. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00996.2014 · Cited by 6
Development of Tinnitus at a Low Dose of Sertraline: Clinical Course and Proposed Mechanisms
Miller, C. W. T. (2016) · Case Reports in Psychiatry · doi:10.1155/2016/1790692 · Cited by 5
Animal Models and Hallucinogenic Drugs
Kozlenkov, A., & González‐Maeso, J. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4121-2_14 · Cited by 5
Subtraction and division of visual cortical population responses by the serotonergic systemPreprint
Azimi, Z., Spoida, K., Barzan, R., Wollenweber, P., Mark, M. D., Herlitze, S., & Jancke, D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/444943 · Cited by 6
Li, L.-F., Zhang, L.-Z., He, Z.-X., Zhang, Y.-T., Ma, H., Xun, Y.-F., Yuan, W., Hou, W.-J., Li, Y.-T., Lv, Z.-J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.21.307280 · Cited by 5
Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model
Kandilakis, C. L., & Papatheodoropoulos, C. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00892 · Cited by 5
Exploring a Druggable Hydrophobic Tunnel in the 5-HT2A Receptor with Potent Phenethylamines
Simon, Í. A., Pottie, E., Jensen, M. K., Harpsøe, K., Jensen, A. A., Kristensen, J. L., Stove, C. P., & Poulie, C. B. M. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01973 · Cited by 4
Olson, R. J., Bartlett, L., Sonneborn, A., Milton, R., Bretton-Granatoor, Z., Firdous, A., Harris, A. Z., & Abbas, A. I. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110030 · Cited by 6
Neuromodulation of Hippocampal Cells and Circuits
Lawrence, J. J., & Cobb, S. (2018) · Springer series in computational neuroscience · doi:10.1007/978-3-319-99103-0_7 · Cited by 4
Synapsin II Directly Suppresses Epileptic Seizures In Vivo
Schwark, R., Andrade, R., & Bykhovskaia, M. (2022) · Brain Sciences · doi:10.3390/brainsci12030325 · Cited by 4
Making Sense of Psychedelics in the CNS
Fordyce, B. A., & Roth, B. L. (2024) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyae007 · Cited by 4
Švrakić, D. M., Mofsen, A. M., Chockalingam, R., Divac-Jovanović, M., & Zorumski, C. F. (2019) · Psychiatria Danubina · doi:10.24869/psyd.2019.290 · Cited by 4
Ramos-Rosales, D. F., Méndez-Hernández, E. M., Salas-Pacheco, J. M., Salas-Leal, A. C., Úrtiz-Estrada, N., Barraza-Salas, M., & Peña, P. P. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136611 · Cited by 3
Absence of sex differences in serotonergic control of orbitofrontal cortex neuronal activity
Mooney, K., Hoffman, A. F., & Lupica, C. R. (2025) · Scientific Reports · doi:10.1038/s41598-025-11208-2 · Cited by 4
Meza, R. C., Morales-Weil, K., Ancatén-González, C., Escobar, A. P., Alcaino, A., Sanguinetti, N. K., Delpire, E. J., Moya, P. R., Chiu, C. Q., Fuenzalida, M., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02364-8 · Cited by 3
Rapid dynamics of dorsal raphe serotonin neurons regulate the strength of visual attention
Lehnert, J., Cha, K., Forestell, J., Yang, K., Ma, X., Shariff, S., Britt, J. P., Khadra, A., Cook, E. P., & Krishnaswamy, A. (2026) · Nature Communications · doi:10.1038/s41467-026-70658-y · Cited by 3
Effects of ayahuasca on fear and anxiety: cross-talk between 5HT1A and 5HT2A receptors
Guerra, L. T. L., SANTOS, R. G. D., & Hallak, J. E. C. (2024) · Psychedelics. · doi:10.61373/pp024i.0037 · Cited by 3
Rudy, L. M., & Godlewski, M. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157233 · Cited by 4
Matsuoka, T., 上松, 浩., Iwakiri, S., & Itoi, K. (2013) · PubMed · Cited by 2
Cellular effects of serotonin in the CNS
Andrade, R., & Haj‐Dahmane, S. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00015-3 · Cited by 3
Denomme, N., Hernández, C. C., Bock, H. A., Ohana, R. F., Bakshi, S., Sherwood, A. M., McCorvy, J. D., Daley, P. F., Callaway, W. B., Hull, J. M., et al. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.123.000837 · Cited by 2
The compulsive eating paradigm: can psychedelics help in treating obesity?
Ammineni, D., & Park, R. J. (2025) · Journal of Eating Disorders · doi:10.1186/s40337-024-01186-7 · Cited by 2
Kim, J., Vanrobaeys, Y. S., Rajan, R., Davatolhagh, M. F., Kelvington, B. A., Chatterjee, S., Ferri, S. L., Angelakos, C. C., Mills, A. A., Fuccillo, M. V., et al. (2026) · Nature Communications · doi:10.1038/s41467-025-68047-y · Cited by 11
Rudin, D., Ren, X., Liechti, M. E., Huang, N., & Arias, H. R. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04727-5 · Cited by 3
A gedanken experiment to find a neuroanatomical model for post-traumatic stress disorder
Eggers, A. E. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.10.021 · Cited by 2
Neuromodulatory mechanisms of N,N-dimethyltryptamine
Jiménez, J. H. (2023) · Brain Network and Modulation · doi:10.4103/2773-2398.386227 · Cited by 3
Beerens, S., Winterer, J., Lukacsovich, D., Földy, C., & Wozny, C. (2022) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-225584 · Cited by 2
Crosstalk Between 5-HT2A and mGlu2 Receptors: Implications in Schizophrenia and Its Treatment
Moreno, J. L., & González‐Maeso, J. (2018) · Springer eBooks · doi:10.1007/978-3-319-70474-6_7 · Cited by 2
Lotter, L., Kohl, S. H., Gerloff, C., Bell, L., Niephaus, A., Kruppa, J. A., Dukart, J., Schulte-Rüther, M., Reindl, V., & Konrad, K. (2022) · bioRxiv · doi:10.1101/2022.07.26.501562 · Cited by 51
Hsiao, Y., Fonseca, M. A., Tiemroth, A. S., Vasquez, E. J., & Gomez, A. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.16.633439 · Cited by 2
Kelly, T. J., & Liu, Q.-S. (2024) · Psychedelics. · doi:10.61373/pp024b.0019 · Cited by 1
Rama, R., Qi, G., Radnikow, G., Yang, D., & Feldmeyer, D. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70573 · Cited by 1
Snapshot IP 1 Detection Following 5-HT 2 A Receptor Stimulation in the Mouse Brain
Revenga, M. D. L. F., & González‐Maeso, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00932 · Cited by 1
Seiriki, K. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00169 · Cited by 1
[18F]R91150: Improved radiosynthesis and in vivo evaluation as imaging probe for 5-HT2A receptors.
Hoffmann, C., Endepols, H., Urusova, E., Elchine, D., Neumaier, F., Neumaier, B., & Zlatopolskiy, B. (2025) · European journal of medicinal chemistry · doi:10.1016/j.ejmech.2025.117265
Zhao, X., Meyers, K. T., McBride, A., Marballi, K. K., Maple, A. M., Beck, K. L., Kang, P. T., Palner, M., Overgaard, A., Knudsen, G. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/634410 · Cited by 1
Neurovascular Uncoupling: Multimodal Imaging Delineates the Acute Effects of MDMAPreprint
Ionescu, T. M., Amend, M., Watabe, T., Hatazawa, J., Maurer, A., Reischl, G., Pichler, B. J., Wehrl, H. F., & Herfert, K. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.14.480365 · Cited by 1
The classic psychedelic DOI induces a persistent desynchronized state in medial prefrontal cortexPreprint
Olson, R. J., Bartlett, L., Sonneborn, A., Bretton-Granatoor, Z., Firdous, A., Harris, A. Z., & Abbas, A. I. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.26.529963 · Cited by 1
Ozols, A. B., Wei, J., Campbell, J. M., Hu, C., Qiu, S., & Gallitano, A. L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.21.595211 · Cited by 1
The impact of the serotonergic psychedelic DOI on active vision in freely moving micePreprint
Skyberg, R. J., Fields, C. W., Martins, D. M., & Niell, C. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.14.682230 · Cited by 1
Bhagavan, C., Carter, O. L., Nielsen, G., Berlowitz, D. J., Issak, S., Braat, S., Zaloumis, S. G., Attard, Z., Oliver, G., Mayne, D., et al. (2025) · medRxiv · doi:10.64898/2025.12.22.25342874 · Cited by 1
Cannabinoid Regulation of Serotonin 2A (5-HT 2A ) Receptor Signaling
Franklin, J. M. (2013)
5HT2A Receptor Antagonist Treatment for Repetitive Behaviors and Restricted Interests in BTBR Mice
Amodeo, D. A. (2015) · Figshare
The role of serotonin in cortical excitability and network dynamics
Puzerey, P. A. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Controlling Prefrontal Attention Circuits: Neuromodulation of Cortical Layer 6 and its Local Outputs
Tian, M. K. (2017) · TSpace (University of Toronto)
Mallmanna, B., Tonini, C., Chielle, E., & Chielle, E. O. (2019) · Archives in Biosciences & Health · doi:10.18593/abh.20573
Ramos-Rosales, D. F., Méndez-Hernández, E. M., Salas, J. M., Salas, A. C., Úrtiz-Estrada, N., & Barraza, M. (2020) · doi:10.21203/rs.3.rs-42474/v1
Herian, M., Adam, W., Maćkowiak, M., Agnieszka, B.-W., Solarz, A., Bysiek, A., Katarzyna, M., & Gołembiowska, K. (2021) · Research Square · doi:10.21203/rs.3.rs-963701/v1
The good, the bad, and the intoxicated
Mason, N. L. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210608nm
Roberts, A. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.5187956.5126054
Snapshot of 5-HT 2A receptor activation in the mouse brain via IP 1 detectionPreprint
Revenga, M. D. L. F., & González‐Maeso, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.11.617861
Fan, L., Deng, B., Hao, X., Qiu, X., & Liu, Y. (2024) · Neuroscience Letters · doi:10.1016/j.neulet.2024.138034
Morici, J. F., Imperatori, M., Koss, P., Zanoni, M. B., Sacson, A., Bekinschtein, P., & Weisstaub, N. V. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00079
Vlotinou, P., Christodoulou, K., Tsiakiri, A., Christidi, F., & Serdari, A. (2025) · Brazilian Journal of Science · doi:10.14295/bjs.v4i10.785
Leptourgos, P. (2018) · theses.fr (ABES) · doi:10.70675/dafacdb1z9072z4ec2z8cebz0ca09b93b7ce · Cited by 3
Metadata
- Authors
- Weber
- Affiliations
- Wayne State University (US)
- Corresponding author
- Weber
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2010
- Volume
- 4
- ISSN
- 1662-453X (ISSN-L)
- PMC
- PMC2928707
- OpenAlex
- W2166045982
- Cited by
- 205
- References
- 53
- Citations by year
- 2026: 16 · 2025: 10 · 2024: 16 · 2023: 17 · 2022: 17 · 2021: 17 · 2020: 13 · 2019: 14 · 2018: 12 · 2017: 8 · 2016: 9 · 2015: 16 · 2014: 9 · 2013: 9 · 2012: 8
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health
- National Institute of Mental Health (R01MH043985)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- HTR2A, 5-HT2A receptor, cerebral cortex, serotonin receptors, cortical cell types, layer 5 pyramidal neurons, GABAergic interneurons, parvalbumin interneurons, fast-spiking interneurons, receptor knockout mice, BAC transgenic mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review